Stay updated on IMM60 and Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-24T18:11:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T18:17:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website footer’s revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T19:08:36.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 is added to the history, and the previous v3.6.6 entry is removed.
    Difference
    0.1%
    Check dated 2026-09-19T18:58:50.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Record history adds revision v3.6.6 and removes revision v3.6.5, reflecting an updated version in the study's history log.
    Difference
    0.1%
    Check dated 2026-08-29T19:46:47.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.6.5 has been added, replacing the previous v3.6.4, indicating an administrative update to the page rather than a substantive change to the study data.
    Difference
    0.1%
    Check dated 2026-08-08T16:44:56.000Z thumbnail image

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.